ABEL NOSER FINISHES YEAR WITH AN IMPRESSIVE LIST OF ACHIEVEMENTS

Highlights Include New Product Launches, Numerous Industry Partnerships, and a Ramping Up of Trade Surveillance Services

New York, NY, Dec 30 (Bernama-GLOBE NEWSWIRE) -- Abel Noser Holdings, the market leader in institutional trade analytics and agency-only trading solutions, has many notable achievements to look back on this year as 2022 comes to a close.  

For instance, the company’s analytics arm, Abel Noser Solutions, began offering a first-of-its-kind global options TCA product that covers all options strategies from covered calls to complex spread strategies.  The offering enables clients to quantify the transaction costs of options hedging, income and more speculative strategies while evaluating broker performance metrics and execution quality.  There were also many enhancements to the firm’s fixed income TCA product suite.  

Subsidiary Zeno AN Solutions launched an ESG-agnostic consensus ratings product for asset owners that provides portfolio-level analysis to help assess, measure and monitor the degree to which manager practices are consistent with client ESG policies. On the broker-dealer side, Abel Noser LLC’s revolutionary START platform, a customizable execution algorithmic solution integrated with industry-leading analytics, was rolled-out as a way for fund managers to proactively meet diversity and inclusion goals through a network of participating MWBE brokers while also mitigating best execution risk in an increasingly challenging trading environment. 

Sell-side regulatory services had a busy year including partnering with Capital Market Solutions to offer clients comprehensive FINRA CAT and CAIS solutions before key 2022 deadlines. Additionally, the group developed a set of new regulatory tools to help brokers identify improper or illegal trading activity while also evidencing best execution.  Firm clients continue to call for cost-effective auditing and reporting tools, as well as regulatory services to mitigate their ongoing risk of potential fines or damage to their reputations.  

2022 was also a busy year for Abel Noser channel partnerships including strategic liaisons with major industry players like JP Morgan’s Neovest.  Partnerships with more niche players included working with the Hackett Group for MWBE brokerage programs, and OWL ESG for consensus ESG data that powers the new fund holdings analysis product.  

“As for the coming year, Abel Noser expects best execution requirements for brokers and managers to continue to be updated and quantified including calls for more fixed income transparency, pending updates to SEC Rule 605 and various FINRA directives,” remarked Peter Weiler, Co-CEO of Abel Noser Holdings. “We also expect a continued ramping up of electronic and algorithmic trading, plus greater emphasis on trading clarity and oversight from all sectors.”  

 “We’re proud of the many successes our top-notch team has accomplished this past year,” added Steve Glass, Co-CEO of Abel Noser Holdings. “We again look forward to applying the firm’s resources and leading position as the overall market matures and becomes more data-driven.”

About Abel Noser Holdings
Abel Noser has long been respected as a leader in the campaign to lower the costs associated with trading. Abel Noser Solutions, the company’s analytics subsidiary, is the industry-leading provider of transaction cost analysis with hundreds of global clients subscribing to its multi-asset TCA and compliance products through a network of resellers, distribution partners and strategic alliances. Abel Noser LLC, the company’s registered broker-dealer and a member of FINRA, SIPC and MSRB, provides a wide range of agency-only trading, transition management, and analytics services to institutional asset owners, investment managers and brokers. Learn more at www.abelnoser.com. 

http://mrem.bernama.com/viewsm.php?idm=45132

ST KITTS AND NEVIS INTRODUCES RAFT OF CHANGES TO ITS CITIZENSHIP BY INVESTMENT PROGRAMME, BENEFITS BOTH LOCALS AND AN INTELLIGENT INVESTOR

London, Dec 28 (Bernama-GLOBE NEWSWIRE) -- The much-anticipated changes to St Kitts and Nevis’ Citizenship by Investment Programme have been announced today by the country’s recently appointed Citizenship by Investment Unit Head, Michael Martin. Setting a bold and new tone for the industry as a whole, St Kitts and Nevis is once again leading the way for the investment immigration industry – adding a new layer of integrity to truly accelerate the country’s economic diversification, empower and prosper local citizens while creating an enriching base for intelligent investors.

“Today, our progressive government brings to fruition these much-awaited and very important changes to our much-loved Citizenship by Investment Programme. Today marks a new era for the investment immigration industry as we boldly declare that a clear strategy will drive our Citizenship by Investment Programme with the sole purpose of benefiting our people and investors who want to see our nation flourish.”

“Today these changes show the international community that we place honesty and integrity above all else as we look to deliver a product that will bring us a positive reputation and send a clear message that we are open for business,” said Michael Martin.

Watch the full video announcement here.

The changes have been gazetted on 23 December 2022 and will take effect on 1 January 2023.

Since his election in August, the Prime Minister of St Kitts and Nevis, Dr Terrance Drew, has hinted at upcoming changes to the country’s Citizenship by Investment programme – reiterating multiple times that the revamped programme needs to be mutually beneficial to both Kittians and Nevisians and international investors.

The Prime Minister said at a recent event “While we navigate the complexities of managing a small island developing state in this unpredictable and highly globalized world, we have made it a priority to craft a solution to ensure that the evolution of our citizenship programme will be a sustainable model filled with integrity, transparency and accountability.”

The Programme will be underpinned by three fundamental principles that have guided the administration’s decision making with respect to the evolved version of the twin-island’s Citizenship by Investment Programme – sustainability, good governance and pragmatism.

“We have crafted a sustainable model that will continue to be the envy of the international community by injecting high levels of integrity that will come through administrative improvements. We have also structured our programme to allow for greater transparency and accountability, which make the hallmarks of a good governance framework that solidifies the foundation of any successful endeavour. Lastly, we have tailored our investment options to align with market realities while preserving the platinum brand our proud nation has developed and nurtured for four decades, operating the oldest Citizenship by Investment Programme in the world,” added the Prime Minister.

To achieve this, the most notable change to the programme will be the introduction of a Board of Governors and a Technical Committee.

Effective next year, a professional Citizenship by Investment Board of Governors will be responsible for high level supervisory matters such as providing general oversight of the operations the CBI Unit, developing and implementing policies and procedures for the CBI Unit, ensuring that application processing is completed as swiftly as possible within the time frames advertised without comprising the integrity of the programme and, continuously monitoring the global investor immigration industry to ensure that the country’s Citizenship by Investment regulations align with and adjust to, international market forces.

To further the Programme’s good governance agenda, a Citizenship by Investment Technical Committee will be charged with ensuring that all due diligence background checks are comprehensive and that all citizenship by investment applications are reviewed thoroughly. This committee will also be tasked with making recommendations to the Prime Minister in his capacity as Minister of National Security, Immigration and Citizenship.

The Technical Committee will be comprised of a chairperson, this role will be filled by the recently appointed Head of the CBI Unit, Michael Martin; a senior officer and a secretary – who will be a civil servant assigned by the Prime Minister.
 

Applicants can gain second citizenship in 60 days, but only for a limited time

St Kitts and Nevis is offering applicants a chance to gain second citizenship in as little as 60 days through its Sustainable Growth Fund - the revenue from the fund is aimed to facilitate economic development and social upliftment in the country. The Sustainable Growth Fund will be used to provide financial support to educational institutions, medical facilities, as well as provide additional funding for the construction of infrastructure, the development of local tourism, the preservation of local culture and heritage and support of sustainable growth initiatives in the twin-island nation.

The Sustainable Growth Fund remains the quickest and easiest route to second citizenship in St Kitts and Nevis and from 1 January to 30 June 2023, for a Limited Time Offer, a main applicant, following stringent background checks, can make a minimum investment of US$125,000 to the Fund and receive approval in principle within 60 days of submission of application.

Under the Limited Time Offer, investment options are as follows:

• Single applicant – US$ 125,000
• Main applicant and a spouse – US$150,000
• Main applicant, spouse and two dependants – US$170,000
• Each additional dependant under 18 – US$10,000
• Each additional dependant over 18 – US$25,000

 
From 1 July 2023 onwards, applicants investing through the Sustainable Growth Fund will be charged as follows and can expect approval in principle within 90 days of submission of application.

• Main applicant – US$150,000
• Main applicant and a spouse – US$175,000
• Main applicant, spouse and two dependants – US$195,000
• Each additional dependant under 18 – US$10,000
• Each additional dependant over 18 – US$25,000

 
These changes are part of the government’s tireless efforts to create conditions necessary for sustainable economic growth and diverse business opportunities.

“This is an exciting time because these policies will continue our progressive course in the global investor immigration industry and cement St Kitts and Nevis’ place as a leader in the Citizenship by Investment space. As we move toward a brand-new diversified economy, we remain committed to investing in tangible projects to uplift the country to achieve our goal of establishing a sustainable island state,” continued the Prime Minister.

It is important to note that these additional layers are not meant to hinder the application process but rather ensure multiple aspects including keeping processing to agreed timelines, all approved applicants are of the highest repute and most importantly, that projects meet the requirement of benefitting the local economy.

Another change is that the sustainable model of the Citizenship by Investment programme will now involve the implementation of an improved multi-faceted approved real estate application process, the removal of loopholes and the strict enforcement of escrow and project milestone requirements. 

The evolved St Kitts and Nevis Citizenship by Investment Programme will invite bold and creative investors to facilitate the development of innovative industries in St Kitts and Nevis including construction of real estate developments pursuant to the new administration’s priority infrastructure list. “All projects must bring substantial benefit to the people of St Kitts and Nevis,” noted the Prime Minister.

The government will approve real estate projects to be developed and of these, a designated number of real estate units will be available to be sold to qualifying investors. Real estate projects will be constructed and completed according to a pre-defined schedule and a designated escrow drawdown process will also be implemented.

Only approved real estate developments will be eligible for the Citizenship by Investment option and most importantly, current “Approved Projects” will lose this designation once the new Citizenship by Investment regulations have been gazetted and approved, meaning stakeholders of these projects will need to apply afresh to become an “Approved Development”.

Minimum investment for approved real estate will remain at US$200,000 but there will be an introduction of penalties for the circumvention of minimum investment sums including:

• Fines of up to US$200,000 on summary conviction
• Revocation/suspension of Approved Development status
• Removal of Authorised Agent licence
• Blacklisting on the Citizenship by Investment website as a person or entity not authorised to submit a Citizenship b Investment application

A new Public Good Investment Option (PGIO) will replace the Alternative Investment Option (AIO) and will focus on effecting real transformation for the country by investing into areas that will benefit the citizens of St Kitts and Nevis – these projects must maximise local employment, transfer technological skills and increase capacity building. Investors of the PGIO must assume all financial risks associated with the projects and, if the investment results in the development of real estate on State land, investors must agree to transfer all real estate to the State on substantial completion. Investors looking to contribute to the PGIO will be required to apply to the Board of Governors to be designated as a Public Good Investor. To qualify under the PGIO, an applicant must contribute US$175,000, excluding relevant due diligence, processing and Government fees.

Investors can also apply for citizenship through the purchase of a qualified private home, for a minimum investment of US$400 000.00 for each main applicant. Unlike the preapproved real estate option, investing through a private home means a single-family home is sold as one unit and cannot be converted into apartments, condominiums or divided otherwise. The use of shares is also prohibited.

A private home that has been purchased through the Citizenship by Investment Programme cannot be sold for a period of five years after the granting of the citizenship and the property may never be eligible for use in a subsequent Citizenship by Investment application.

Having established the citizenship by investment industry 40 years ago, the progressive government of St Kitts and Nevis believes that these changes to its programme will once again set a much-needed positive tone and direction in the investor immigration industry.

St Kitts and Nevis has created a name for itself as a financial nexus with an attractive citizenship programme underpinned by a sound legal framework and robust multi-layered due diligence.   

For nearly 40 years, St Kitts and Nevis has been the pioneer of the global investor immigration industry.

Watch the full video announcement here. 

http://mrem.bernama.com/viewsm.php?idm=45123

Gartner Magic Quadrant for Network Firewalls names Hillstone Networks as a visionary again

KUALA LUMPUR, Dec 23 (Bernama) -- China’s Hillstone Networks, an innovative and accessible cybersecurity solutions provider, has been named a Visionary in the 2022 Gartner Magic Quadrant for Network Firewalls for the second time and recognised for the ninth consecutive year.

In a statement, the company said that its solutions have evolved from a network security platform into a robust cybersecurity portfolio that delivers on cyber resilience, from edge to cloud, and everything in between.

Hillstone Networks said its portfolio leverages the foundational Next Generation Firewall (NGFW) to include solutions such as Hillstone Secure SD-WAN for distributed enterprises and Hillstone Zero Trust Network Access (ZTNA) that enables Zero Trust access from any device, anywhere.

“Other solutions include Hillstone CloudArmour delivering cloud workload protection and Hillstone CloudHive micro-segmentation solution for virtualised data centres,” it added.

Hillstone Networks chief technology officer and co-founder Tim Liu said the company’s cloud-first strategy resonates with customers and partners in today’s hybrid multi-cloudworld.

“We continue to leverage the award-winning and industry-leading NGFW platform and integrate advanced features to unlock SD-WAN and ZTNA capabilities and deliver additional solutions that meet gaps in the market as well as address the needs of our growing customer base,” he said.

Beyond on-premises, private and hybrid cloud environments, the Hillstone Networks solution repertoire includes the internet of things (IoT) security that helps the IoT sector proactively detect, protect, and manage risk across IoT devices.

-- BERNAMA

AM BEST REVISES OUTLOOKS TO NEGATIVE FOR PT ASURANSI TUGU PRATAMA INDONESIA TBK

SINGAPORE, Dec 23 (Bernama-BUSINESS WIRE) -- AM Best has revised the outlooks to negative from stable and affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) of PT Asuransi Tugu Pratama Indonesia Tbk (TUGU) (Indonesia).

The Credit Ratings (ratings) reflect TUGU’s balance sheet strength, which AM Best assesses as very strong, as well as its strong operating performance, neutral business profile and appropriate enterprise risk management. The ratings also factor in a neutral impact from TUGU’s ultimate majority parent, PT Pertamina (Persero) (Pertamina), a state-owned energy company in Indonesia.

The revision of the outlooks to negative from stable reflect the trend of deterioration in TUGU's underwriting performance over recent periods, and AM Best’s expectation for overall operating performance to remain constrained over the near to medium term.

TUGU’s balance sheet strength is underpinned by its risk-adjusted capitalisation, as measured by Best’s Capital Adequacy Ratio (BCAR), which remains at the strongest level. Capital adequacy is supported by its low net underwriting leverage and ongoing internal capital generation. TUGU’s investment portfolio is viewed to be of moderate risk and generally diversified. Cash, deposits and bonds made up more than half of its total investments in 2021, with the remainder in investment properties and equity investments. An offsetting factor is TUGU’s dependence on reinsurance to support the underwriting of large commercial risks, including aviation and energy business. The majority of reinsurance assets are of good credit quality although TUGU maintains some exposure to reinsurance counterparties that are not rated on an international financial strength rating scale.

AM Best views TUGU’s operating performance as strong. Profitable business from its parent group, PT Pertamina (Persero) (Pertamina), remains the key contributor to TUGU’s strong operating performance. However, underwriting performance has deteriorated in the two most recent financial years, accompanied by an increasing trend of operating expense ratio, and underwriting losses at its reinsurance subsidiary, PT Tugu Reasuransi Indonesia (Tugu Re). Pre-tax profits increased 15% in the first nine months of 2022 compared with the same period in 2021 supported by higher investment income although underwriting performance remains below historical achievements. Despite ongoing portfolio remediation measures, recovery in consolidated performance to the robust level of profitability seen prior to 2020 may remain challenged by claims normalisation, tighter reinsurance market conditions, and volatility arising from Tugu Re’s exposure to legacy credit, life and health reinsurance over the near to medium term.

AM Best considers TUGU’s business profile to be neutral. TUGU is a large insurance group in Indonesia, ranking number five by market share in 2021 in the domestic general insurance market, and additionally writes reinsurance through Tugu Re. TUGU has a strong market position in commercial and industrial risks, including the energy, aviation and engineering business segments, and benefits from favourable business access to affiliated business from the Pertamina group. Business diversification is expected to be supported by strategic expansion to the non-captive corporate sector and retail business over time, although this may also lead to greater underwriting volatility over the near to medium term.

Ratings are communicated to rated entities prior to publication. Unless stated otherwise, the ratings were not amended subsequent to that communication.

This press release relates to Credit Ratings that have been published on AM Best’s website.

For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best’s Credit Ratings. For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments.

AM Best is a global credit rating agency, news publisher and data analytics provider specialising in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2022 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED. 

http://mrem.bernama.com/viewsm.php?idm=45104

QUANTEXA POSITIONED BY GLOBAL RISK ANALYST FIRM CHARTIS AS A CATEGORY LEADER IN 2023 RISKTECH 100 REPORT FOR TRADE-BASED MONEY LAUNDERING SOLUTIONS

Chartis also gave top ranking to Quantexa’s Entity Resolution solution – addressing key data management challenges that are costing financial institutions millions

LONDON, Dec 23 (Bernama-GLOBE NEWSWIRE) -- Today Quantexa, a global leader in Decision Intelligence (DI) solutions for the public and private sectors, announced that their Decision Intelligence Platform has been recognized as a category leader in the Chartis RiskTech100 report for Trade-Based Anti-Money Laundering Solutions (TBAML). Quantexa’s Decision Intelligence Platform has also been recognized by Chartis as a category leader in the recently released Chartis Financial Crime Risk Management Systems, Entity Management and Analytics Quadrant report.

RiskTech 100: Trade-Based Anti-Money Laundering Solutions
The 2023 RiskTech100 report ranks the world’s major players in risk and compliance technology. In the Trade-based money laundering (TBML) category Quantexa was named as a category leader for data support of their enterprise solution. The Quantexa Trade AML Solution was also ranked for depth of typology coverage, breadth of analytical techniques and workflow.

Today’s Anti-money laundering efforts face many growing and unresolved challenges. In a digital and globalized world, criminals are using a wide range of strategies to be successful – making context a critical factor in the ability to accurately detect trade-based money laundering. By unifying internal and external data sources and scaling to understand billions of transactions, Quantexa’s Decision Intelligence Platform helps organizations create a holistic view of transactional, customer, and counterparty information. Quantexa’s approach to TBAML provides more accurate and efficient detection so organizations can reduce risk, assure compliance, and protect their reputation. Increased alert quality and automation, combined with reducing the volume of false positives helps organizations gain efficiencies and do more with the resources they already have.

Financial Crime Risk Management Systems: Entity Resolution
Quantexa’s dynamic Entity Resolution Solution capability that is a critical part of its industry leading Decision Intelligence Platform was recognized for coverage, scalability, data enrichment, depth and breadth of data sources supported.

Quantexa’s Entity Resolution Solution is an advanced data matching capability that connects disparate and ambiguous internal and external data at scale. Entity Resolution creates focused and complete views of people, organizations, places, and other data delivering game changing data quality and match rate accuracy. Quantexa also supports ‘dynamic entity resolution’, which gives unique flexibility across multiple use cases and informs granular and extensive security protocols.

Decision Intelligence Platform
Quantexa’s Decision Intelligence Platform gives enterprises the ability to unify their data by connecting siloed sources and systems, providing the context needed to visualize the complex relationships that enable previously hidden risk to be discovered. Quantexa's unique entity resolution technology can connect the most disparate and ambiguous internal and external data at scale to create single, complete views of people, organizations, places, and other data with 99% accuracy, handling poor quality data with exceptional performance. The result is a single view of data that becomes their most trusted and reusable resource across the organization.

Chartis Chief Researcher Sidhartha Dash said:

“Quantexa’s increasingly mature solutions and their strong implementations in large financial institutions leveraging network-based concepts, drove their rise in the RiskTech 100 as well as their leadership in TBAML and Entity Management quadrants.”

Quantexa Chief Product Officer Dan Higgins added:

“Quantexa is delighted to be included in the RiskTech 100 report, positioned very strongly amongst an esteemed list of enterprise solution providers. At Quantexa, we are keenly aware that criminals are hiding in plain sight and that traditional monitoring systems and manual controls just can’t handle today’s complexity, scale of activity and the underlying regulatory shifts, in particular the focus on counterparty risk, as well as customers. The usage of contextual monitoring to detect and manage the holistic financial crime and fraud risks within International Trade, including the identification of prerequisites such as underlying collusion, the presence of shell companies and professional money laundering gatekeeps and enablers has been a defining factor in Quantexa’s success in this space.”

ABOUT QUANTEXA

Quantexa is a global data and analytics software company pioneering Contextual Decision Intelligence that empowers organizations to make trusted operational decisions by making data meaningful. Using the latest advancements in big data and AI, Quantexa’s platform uncovers hidden risk and new opportunities by providing a contextual, connected view of internal and external data in a single place. It solves major challenges across data management, KYC, customer intelligence, financial crime, risk, fraud, and security, throughout the customer lifecycle.

The Quantexa Decision Intelligence Platform enhances operational performance with over 90% more accuracy and 60 times faster analytical model resolution than traditional approaches. Founded in 2016, Quantexa now has more than 500 employees and thousands of users working with billions of transactions and data points across the world. The company has offices in London, New York, Boston, Washington DC, Brussels, Toronto, Singapore, Melbourne, and Sydney. For more information, contact Quantexa here or follow us on LinkedIn.

ABOUT CHARTIS

Chartis is a research and advisory firm that provides technology and business advice to the global risk management industry. Chartis provides independent market intelligence regarding market dynamics, regulatory trends, technology trends, best practices, competitive landscapes, market sizes, expenditure priorities, and mergers and acquisitions. Chartis’ RiskTech Quadrant reports are written by experienced analysts with hands-on experience of selecting, developing, and implementing risk management systems for a variety of international companies in a range of industries, including banking, insurance, capital markets, energy, and the public sector. 

http://mrem.bernama.com/viewsm.php?idm=45103

SYNCHRONOSS ANNOUNCES MORE THAN 30 MILLION RCS-BASED MESSAGING SUBSCRIBERS IN JAPAN

Leveraging the Synchronoss Advanced Messaging Platform, NTT DOCOMO, KDDI, and SoftBank Deliver Cross-Operator Advanced Messaging Service Enabling Users and Brands to Communicate, Interact, and Transact

BRIDGEWATER, N.J., Dec 22 (Bernama-GLOBE NEWSWIRE) -- Synchronoss Technologies, Inc. (“Synchronoss” or the “Company”) (NASDAQ: SNCR), a global leader and innovator in cloud, messaging and digital products and platforms, today announced a new milestone in Japan for its Synchronoss Advanced Messaging platform. In collaboration with mobile operators NTT DOCOMO, KDDI, and SoftBank, the Japanese consortium now supports 32.5 million subscribers of +Message, the cross-operator RCS service powered by Synchronoss Advanced Messaging.

The current milestone represents a 62 percent increase in subscribers since Synchronoss noted the progress of the Japanese consortium’s deployment of its Rich Communications Service (RCS) in November 2020.

Offering a feature-rich text messaging system, +Messaging allows Japanese users to communicate with friends and family, in addition to providing the capability to interact and engage with brands and businesses safely and securely.

The consortium’s +Messaging service is powered by Synchronoss Advanced Messaging, an end-to-end platform and mobile commerce suite that allows operators to deliver an advanced messaging ecosystem. Synchronoss Advanced Messaging connects brands and content providers with subscribers, offering new ways to communicate and transact commerce. 

http://mrem.bernama.com/viewsm.php?idm=45094

INNIO AND NORTHC DATACENTERS TO BUILD FIRST HYDROGEN EMERGENCY BACKUP POWER SOLUTION WITH ENGINES GLOBALLY

 

· Lighthouse project will comprise first data center worldwide with green H_₂-engines in the 1-MW class
· Six Jenbacher engines, each 1 MW, will provide emergency backup power with green H_₂
· Jenbacher hydrogen engines replace traditionally used diesel generators as emergency backup solution 

EINDHOVEN, Netherlands, Dec 22 (Bernama-BUSINESS WIRE) -- INNIO today announced that its Jenbacher Ready for H_₂ engine technology has been selected by NorthC Datacenters (NorthC) to deliver an emergency backup power solution for its newest data center, which will be constructed in Eindhoven, Netherlands. Six Jenbacher hydrogen engines will provide carbon-free emergency backup power in cases of electricity grid outages. The Jenbacher Type 4 hydrogen engines generate a total power output of six megawatt and will be delivered as a containerized package. The Eindhoven data center including the hydrogen emergency backup power solution and the onsite hydrogen storage solution is a greenfield project, that is expected to be operational in the second half of 2023.
 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221220005510/en/ 

“We are excited and proud to build the first 100% green hydrogen emergency backup power solution with engines for data centers globally together with NorthC,” said Dr. Olaf Berlien, president and CEO of INNIO. “As a carbon-free energy source, hydrogen is an important pillar of the energy transition.”

“We selected INNIO’s Jenbacher technology to support our green hydrogen powered electricity generation because of their long-term experience and proven track record with special gases, like hydrogen,” said Jarno Bloem, COO of NorthC Datacenters. “With INNIO’s Jenbacher hydrogen emergency backup power solution coupled with the renewable power sources from the electricity grid, we are able to decarbonize our complete energy supply infrastructure.”

NorthC has implemented a strategy to be fully carbon neutral by 2030. This will be accomplished through four sustainability pillars: 100% green energy, modular construction, making efficient use of residual heat, and green hydrogen. The Eindhoven data center will be powered with solar and wind energy from the grid.

To provide additional flexibility and security to NorthC the six Jenbacher Type 4 engines are configured as dual-gas engines. In case of an electricity grid outage the engines are operated with the on-site stored hydrogen. For longer duration grid outages, NorthC has the option to switch to natural gas as an energy source during operation of the engines, in case of shortage in the H_₂ supply infrastructure. INNIO’s myPlant Performance cloud-based digital platform solution will provide NorthC secure, real-time monitoring of the emergency backup solution. The project supports the Netherlands strategy to achieve carbon neutrality by 2050.

http://mrem.bernama.com/viewsm.php?idm=45088

Convergent push-to-talk tech among key trends in physical security transformation -- Hytera Communications

 

KUALA LUMPUR, Dec 22 (Bernama) -- Convergent push-to-talk communications technology is among the key trends in physical security transformation, China’s Hytera Communications said.

Hytera Communications, a leading global provider of professional communications technologies and solutions, has released a new white paper titled “Harness Advanced Push-to-talk to Transform Physical Security Operations” that laid out three key trends, namely enterprise transformation; advancing security operation centres with automation and intelligence; and the progression of video security technologies.

“To fulfil the unprecedented growth needs for an effective, adaptable and extensive security posture for years, it is time for security organisations to embrace new digital transformation technologies,” it said in a statement.

The white paper demystified Hytera Communications’s comprehensive security communication solution and the unified collaboration platform, explaining how security organisations can leverage advanced communication systems to promote digital transformation.

The company also shared several cases to demonstrate how the advanced communication solution, while reducing the operation cost, can support security organisations to protect customers and ensure the safety of their own staff by driving more efficiency, effectiveness and productivity of operation and management during daily operations and emergencies.

The white paper showed why forward-looking security companies are embracing advanced push-to-talk technologies for digital transformation.

-- BERNAMA

THIS HOLIDAY SEASON, 90% OF SINGAPOREANS CHOOSE INTERNATIONAL OVER DOMESTIC TRAVEL: USERTESTING SURVEY

Over 50% of respondents revealed taking smaller and simpler trips this season

SINGAPORE, Dec 21 (Bernama-BUSINESS WIRE) -- UserTesting (NYSE: USER), a leader in video-based human insight, recently conducted a survey in Singapore, to understand consumer travel trends this holiday season. As COVID cases have significantly decreased worldwide, the survey revealed that 70% of Singaporeans have a holiday planned this year-end. Interestingly, despite rising costs due to inflation, a large number of Singaporean respondents (90%) are traveling overseas for their next trip, while only 10% are traveling within the country.

However, with increasing prices due to inflation, most Singaporeans are cost-cutting while planning their travels. The survey revealed that 40% of Singaporeans are now taking fewer trips than before, while 40% are opting for cheaper accommodations rather than luxurious stays.

Inflation Leads To Change In Travel Plans

Along with the rest of the world, Singapore too is bearing the brunt of inflation. With regard to travel during the holiday season, 80% of Singaporeans reported altering their plans and taking an economical route by choosing cheaper destinations to keep their expenses in check. According to 50% of Singaporeans, the highest cost spike is being observed in flight tickets, while 30% reported witnessing a sharp uptick in food and city travel prices.

Out of the Singaporeans who are not traveling anywhere this year, 70% are prioritizing savings, thereby making minimal expenses during the last leg of 2022.

Singaporeans Prioritise Family Trips This Holiday Season

Family bonding emerged to be of prime importance for Singaporeans this holiday season. As per the UserTesting survey, 50% of respondents mentioned that they will be traveling with their families instead of friends this year. Additionally, in terms of travel priorities in the near future, 50% of Singaporeans are more inclined towards simple, short, and lowkey vacations while some are also visiting their families to spend quality time with loved ones. However, the overall sentiment for the long run is to plan extended international trips instead.

Meanwhile, 40% of Singaporeans also reported that they want their holidays to be luxurious and wellness-focused with minimum inconvenience and maximum amenities.

International Travel—Top Choice For Singaporeans

As the looming threat of COVID-19 forced many to be stuck inside their homes for more than two years, Singaporeans are now looking to travel more frequently. As per the survey, 80% of Singaporeans stated their willingness to plan more foreign trips instead of traveling within their country. Most respondents stated the reason as wanting to make up for lost time and moving on to explore newer destinations outside of Singapore.

Additionally, Singaporeans are equally balanced when it comes to choosing their dream travel destination, with 20% each for cities, mountains, beaches, countryside, and more.

About UserTesting
UserTesting (NYSE: USER) has fundamentally changed the way organizations get insights from customers with fast, opt-in feedback and experience capture technology. The UserTesting Human Insight Platform taps into our global network of real people and generates video-based recorded experiences, so anyone in an organization can directly ask questions, hear what users say, see what they mean, and understand what it’s actually like to be a customer. Unlike approaches that track user behavior then try to infer what that behavior means, UserTesting reduces guesswork and brings customer experience data to life with human insight. UserTesting has more than 2,500 customers, including more than half of the world’s top 100 most valuable brands according to Forbes. UserTesting is headquartered in San Francisco, California. To learn more, visit www.usertesting.com 

http://mrem.bernama.com/viewsm.php?idm=45081

LIFE SCIENCES PROFESSIONAL PETER MARCHESINI JOINS INDEGENE TO HELP CLIENTS IMPROVE COMMERCIAL OUTCOMES

PRINCETON, N.J. and BENGALURU, India, Dec 20 (Bernama-GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company, today announced the appointment of Peter Marchesini as Senior Vice President to help life sciences companies improve the effectiveness and efficiency of their commercial processes and go-to-market approach.

Peter brings more than 30 years of experience in the life sciences industry. Most recently, he was President of Field Solutions at Eversana. Prior to that, he was the Cofounder and Chief Operating Officer of Alamo Pharma Services. Earlier, Peter served as the Executive Director of Sales and Chief Learning Officer of inVentiv Health, and a member of its steering committee. Peter continues to serve on the faculty of Rutgers Business School Pharmaceutical MBA program and is a three-time honoree of PharmaVoice Magazine’s 100 Most Inspiring Leaders.

At Indegene, Peter will drive strategic client engagement with a focus on the commercial segment of the life sciences value chain. Indegene combines healthcare expertise with data, analytics and insights based on the digital affinity of healthcare professionals, to help life sciences companies personalize their omnichannel experience and improve the effectiveness of their sales efforts.

“Life sciences companies seek operational agility and innovative go-to-market models to enhance their competitiveness. With our digital-first capabilities and healthcare expertise, we are committed to helping clients personalize the experience for patients and physicians across channels,” said Gaurav Kapoor, Executive Vice President of Indegene, Inc. “I am excited to welcome Peter onboard and look forward to helping our clients be future ready.”

“I am inspired by Indegene’s consistent growth, stable leadership, and strong client relationships over the years. I look forward to working with clients to fully realize their commercialization potential through our digital-first approach,” said Peter Marchesini, Senior Vice President, Indegene. “I am thrilled to join Indegene and help life sciences companies evolve their go-to-market strategy and optimize impact through an omnichannel approach.”

About Indegene
We are a digital-first, life sciences commercialization company. We help biopharmaceutical, emerging biotech, and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient, and modern way. We bring together healthcare domain expertise, fit-for-purpose technology, and an agile operating model to provide a diverse range of solutions. These aim to deliver, amongst other outcomes, a personalized, scalable, and omnichannel experience for patients and physicians. It’s what drives our team and our purpose to enable healthcare organizations to be future ready. To learn more, please visit www.indegene.com  

http://mrem.bernama.com/viewsm.php?idm=45072

FOURKITES RECORDS STRONG GROWTH, INNOVATION IN APAC

KUALA LUMPUR, Dec 20 (Bernama) -- Logistics and transportation company FourKites has recorded strong growth in 2022 in its automated, interconnected and collaborative supply chains that span transportation, warehousing, storage.

In a statement today, the company said it has extended its leadership position in the supply chain visibility market with strong growth and innovation in Asia-Pacific (APAC).

The company saw a 91 per cent in new customers growth in the region and more than 240 per cent growth in shipments tracked across 46 APAC countries.

“In 2023, we look forward to helping our APAC customers take the next leap forward in their logistics operations as they expand further. Together, we will build a more resilient and agile supply chain,” said FourKites founder and chief executive officer Mathew Elenjickal.

Its new customers include Mitsui & Co Global Logistics Ltd, Nestlé Japan, Chevron Corporation, Kraft Heinz, SpaceX and QVC.

Globally, the company has recorded nearly 50 per cent year-on-year growth as it continues to connect the supply chains of 50 per cent of the Fortune 500 companies it said.

In addition to strategic investments in 2021 from industry heavyweights Qualcomm Ventures LLC, Volvo Group Venture Capital AB and Zebra Technologies, over the past year, FourKites inked strategic partnerships with a number of industry titans to continue executing its vision for the future of digital supply chains.

These companies include FedEx, Quiet Platforms, Mitsui & Co Ltd, Sony, Microsoft and Narvar.

Among the new solutions released this year include patented ocean shipment innovations that provide international shippers and their partners with complete visibility of all documentation requirements at every leg of the shipment.

Tracking more than three million shipments daily, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains.

-- BERNAMA

AM BEST AFFIRMS CREDIT RATINGS OF QIANHAI REINSURANCE CO., LTD.

HONG KONG, Dec 19 (Bernama-BUSINESS WIRE) -- AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) of Qianhai Reinsurance Co., Ltd. (QHR) (China). The outlook of these Credit Ratings (ratings) is stable.

The ratings reflect QHR’s balance sheet strength, which AM Best assesses as very strong, as well as its adequate operating performance, neutral business profile and appropriate enterprise risk management.

QHR’s risk-adjusted capitalisation, as measured by Best’s Capital Adequacy Ratio (BCAR), remained at the strongest level as of year-end 2021. The capital and surplus increased by 7.1% to RMB 3.3 billion in 2021, underpinned by full retention of net profit. Going forward, AM Best expects the company to continue to receive financial support from its major shareholders and explore opportunities in capital markets to enrich its capital structure. Other supportive factors to the balance sheet strength include the prudent retrocession arrangements and the diversified investment portfolio focused on cash and fixed-income securities, albeit with a moderate exposure to debt-type alternative investments.

The company extended the profitable trend in 2021 with a return on equity of 6.5%, compared with the five-year (2017-2021) average of 2.1%. The company continues to commit resources and strengthen its business relationships with Chinese insurers and distribution partners to tap growth potential in traditional protection products and opportunities in financial reinsurance solutions to improve capital efficiency, while adjusting its risk appetite in long-term savings products in view of heightened challenges in asset-liability matching risk. The life reinsurance segment remains as the major driver of underwriting results. On the other hand, the non-life combined ratio increased in 2021, partially attributed to several large losses during the year, including the Henan floods and some commercial fire events in the overseas portfolio. Interest income from deposits, coupled with returns from bonds, equities and financial products, has continued to support the overall investment results over the past three years. Notwithstanding, unfavourable capital market conditions in the first three quarters of 2022 have put pressure on the valuations of the company’s invested assets, albeit its investment yield remained on par with domestic reinsurer peers.

QHR is a composite reinsurer controlled by three Chinese state-owned enterprises and plays a strategic role in the development of the Qianhai Free Trade Zone. Over the past five years, the company has continued to strengthen its market presence. The non-life underwriting portfolio is diversified by product lines with a focus on Chinese risks as the company rebalanced the overseas book to improve business quality.

Negative rating actions could occur if QHR’s risk-adjusted capitalisation declines significantly due to adverse deviation from its business and capital plan, for example, much faster-than-expected expansion in underwriting and investment risks. Negative rating actions also could occur if the company demonstrates a sustained deteriorating trend in its operating performance.

Ratings are communicated to rated entities prior to publication. Unless stated otherwise, the ratings were not amended subsequent to that communication.

This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best’s Credit Ratings. For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments.

AM Best is a global credit rating agency, news publisher and data analytics provider specialising in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2022 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED. 

http://mrem.bernama.com/viewsm.php?idm=45064

JETEX WELCOMES THE WORLD'S FIRST LOUIS VUITTON POP-UP AT A PRIVATE JET TERMINAL

Private jet flyers enjoy exclusive access to the most dazzling travel selection.

Dubai, United Arab Emirates, Dec 15 (Bernama-GLOBE NEWSWIRE) -- Jetex, an award-winning global leader in executive aviation, is proud to host the world’s first Louis Vuitton pop-up store at its flagship Jetex VIP Terminal in Dubai.

Passengers traveling with Jetex can look forward to getting inspired by Louis Vuitton iconic travel pieces, designed to make private jet flying even more glamorous. From timeless monogram trunks and exotic leather creations to a wide range of city guides and unique Objets Nomades, everyone will find something special from the wide collection of exquisite travel accessories available at the Louis Vuitton pop-up store.

“As Jetex breaks records in terms of passenger numbers, we seek new opportunities to surprise and delight both regular and new clients alike. I am exceptionally pleased that Louis Vuitton chose our FBO in Dubai to unveil its worlds’ first pop-up store at a private aviation terminal,” said Adel Mardini, Founder and CEO of Jetex.

With over 100 international private jet flights and more than 1,000 passengers daily, Jetex VIP Terminal in Dubai is currently one of the busiest globally. In addition to tranquil private lounges, elegant hospitality and curated art exhibitions, Jetex works closely with the leading luxury brands to develop solid, long-term partnerships. 

http://mrem.bernama.com/viewsm.php?idm=45024

A LEADING US FINANCIAL INSTITUTION SELECTS TEMENOS TO MODERNIZE ITS WEALTH MANAGEMENT PLATFORM IN THE CLOUD

Temenos open platform to support leading US Financial Institution’s growth in wealth management

Ad hoc announcement pursuant to Art. 53 LR

GENEVA, Dec 13 (Bernama-GLOBE NEWSWIRE) -- Temenos (SIX: TEMN) today announced that a leading US financial institution is extending its relationship with Temenos to include its international private banking business. The Temenos wealth management platform will support the bank’s strategic transition to a cloud-based core banking system and help drive growth in Europe and the Asia-Pacific (APAC) as it looks to transform its operations and drive efficiencies at scale, while offering first class services and products to its clients.

About Temenos
Temenos (SIX: TEMN) is the world’s leading open platform for composable banking, creating opportunities for over 1.2 billion people around the world every day. We serve over 3000 banks from the largest to challengers and community banks in 150+ countries by helping them build new banking services and state-of-the-art customer experiences. The Temenos open platform helps our top-performing clients achieve return on equity three times the industry average and cost-to-income ratios half the industry average.

For more information, please visit www.temenos.com. 

http://mrem.bernama.com/viewsm.php?idm=45005

TESSA THERAPEUTICS ANNOUNCES UPDATED SAFETY, EFFICACY AND BIOMARKER DATA FROM PHASE 2 TRIAL OF AUTOLOGOUS CD30.CAR-T THERAPY (TT11) IN RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA

Updated Results from CHARIOT Phase 2 trial presented at the 2022 ASH Annual Meeting indicate a 73.3% overall response rate and 60% complete response rate from 15 heavily pre-treated patients dosed with TT11

Research presented in an oral podium presentation during the 2022 ASH Annual Meeting demonstrates potential of circulating tumor DNA (ctDNA) as a biomarker to predict outcomes of patients with r/r classical Hodgkin lymphoma (cHL) treated with CD30.CAR-T therapy

SINGAPORE, Dec 13 (Bernama-GLOBE NEWSWIRE) -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced updated clinical data from the pilot stage of the ongoing Phase 2 CHARIOT trial (NCT04268706) of TT11, the Company’s autologous CD30 chimeric antigen receptor T-cell (CAR-T) therapy, were presented in a poster and oral podium presentation at the 64^rd Annual Meeting of the American Society of Hematology (ASH). The results demonstrated TT11 to be well-tolerated with promising efficacy in relapsed or refractory (r/r) CD30-positive classical Hodgkin lymphoma (cHL). Moreover, research identified circulating tumor DNA (ctDNA) analysis as a potential measure of response in cHL after CD30 targeted CAR T-cell therapy.

The ASH poster, titled, “Updated Results and Correlative Analysis: Autologous CD30.CAR-T Cell Therapy in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (CHARIOT Trial),” reported expanded data from the pilot segment of a Phase 2 trial of autologous CD30.CAR-T in patients with r/r cHL. The CD30.CAR-T cell therapy was demonstrated to be well tolerated with no unexpected safety signals. An ORR of 73.3% and a CR of 60% was observed in 15 heavily pre-treated r/r cHL patients, suggesting strong anti-tumor responses. Additionally, CD30.CAR-T expansion and persistence was observed after CD30.CAR-T infusion.

In an oral podium presentation on December 12, titled, “Ultrasensitive ctDNA Dynamics after Autologous CD30.CAR-T Cell Therapy for Relapsed or Refractory (r/r) Classical Hodgkin Lymphoma (CHARIOT Trial),” research examining the potential of ctDNA as a biomarker in r/r cHL after CD30 CAR-T therapy were reported. Foresight Diagnostics’ PhasED-Seq MRD assay was used to measure ctDNA at multiple timepoints throughout therapy. Data showed that ctDNA responses mirrored radiographic responses, suggesting that ctDNA levels could be predictive of patient response to CAR-T therapy. Researchers also determined that PhasED-Seq ctDNA analysis is a viable biomarker to monitor responses and predict outcomes in patients with r/r cHL treated with CD30.CAR-T Cell Therapy.

“The data presented at ASH 2022 continue to demonstrate the CD30.CAR-T cell therapy to be well tolerated with excellent anti-tumor responses in patients with relapsed or refractory classical Hodgkin lymphoma. This includes an overall response rate of 73.3% in heavily pretreated patients, as well as good expansion and persistence after infusion,” stated Sairah Ahmed, M.D., principal investigator, lead presentation author, and Associate Professor, The University of Texas MD Anderson Cancer Center.

“We are pleased to present research demonstrating the potential of minimally invasive ctDNA analysis as a viable method to monitor responses, rapidly risk stratify, and predict outcomes of patients with r/r cHL treated with CD30.CAR-T therapy,” stated David M. Kurtz, M.D., Ph.D., lead presenter and Assistant Professor, Department of Medicine (Oncology), Stanford University.

CD30 is a well validated lymphoma target with homogeneous expression in 98% of cHL and a significant proportion of subsets of non-Hodgkin lymphoma (NHL). TT11 is an autologous CD30 chimeric antigen receptor T-cell (CAR-T) therapy that harvests the patient’s own T-cells and modifies them to target cancer cells expressing the CD30 protein.

“We continue to be intrigued by the data being generated from our ongoing Phase 2 CHARIOT trial of TT11, which show the therapy to be safe and well tolerated, along with clear signals of efficacy, in patients with relapsed or refractory CD30-positive classical Hodgkin lymphoma,” said Ivan Horak, M.D., Chief Medical Officer and Chief Scientific Officer of Tessa Therapeutics.

TT11 was granted Regenerative Medicine Advanced Therapy (RMAT) designation by the U.S. Food and Drug Administration (FDA) and PRIority MEdicines (PRIME) designation by the European Medicines Agency (EMA).

About Tessa Therapeutics

Tessa Therapeutics is a clinical-stage biotechnology company developing next-generation cell therapies for the treatment of hematological cancers and solid tumors. Tessa’s lead clinical asset, TT11, is an autologous CD30-CAR-T therapy currently being investigated as a potential treatment for relapsed or refractory classical Hodgkin lymphoma as both a monotherapy (Phase 2) and combination therapy (Phase 1b). TT11 has been granted RMAT designation by the FDA and access to the PRIME scheme by European Medicine Agency. Tessa is also advancing an allogeneic “off-the-shelf” cell therapy platform targeting a broad range of cancers in which Epstein Barr Virus Specific T Cells (EBVSTs) are augmented with CD30-CAR. A therapy using this platform is currently the subject of a Phase 1 clinical trial in CD30-positive lymphomas. Tessa has its global headquarters in Singapore, where the company has built a state of the art, commercial cell therapy manufacturing facility. For more information on Tessa, visit www.tessacell.com.  

Cautionary Note on Forward Looking Statements

This press release contains forward-looking statements (within the meaning of the Private Securities Litigation Reform Act of 1995, to the fullest extent applicable) including, without limitation, with respect to various regulatory filings or clinical study developments of the Company. You can identify these statements by the fact that they use words such as “anticipate,” “estimate”, “expect”, “project”, “intend”, “plan”, “believe”, “target”, “may”, “assume” or similar expressions. Any forward-looking statements in this press release are based on management’s current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release, including, without limitation, those related to the Company’s financial results, the ability to raise capital, dependence on strategic partnerships and licensees, the applicability of patents and proprietary technology, the timing for completion of the clinical trials of its product candidates, whether and when, if at all, the Company’s product candidates will receive marketing approval, and competition from other biopharmaceutical companies. The Company cautions you not to place undue reliance on any forward-looking statements, which speak only as of the date they are made, and disclaims any obligation to publicly update or revise any such statements to reflect any change in expectations or in events, conditions or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements. Any forward-looking statements contained in this press release represent the Company’s views only as of the date hereof and should not be relied upon as representing its views as of any subsequent date. The Company’s products are expressly for investigational use pursuant to a relevant investigational device exemption granted by the U.S. Food & Drug Administration, or equivalent competent body. 

http://mrem.bernama.com/viewsm.php?idm=45001

AGC BIOLOGICS AND GORE COLLABORATE ON NEW PROTEIN A-BASED PURIFICATION TECHNOLOGY AND CONTRACT MANUFACTURING SERVICES FOR ANTIBODY THERAPIES

GORE® Protein Capture Devices and AGC Biologics development and manufacturing platforms help advance downstream purification and support effective development and manufacturing

Seattle, Dec 13 (Bernama-GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a collaboration with W.L. Gore & Associates (Gore) that features Protein A affinity purification technology from Gore alongside the CDMO’s contract development and manufacturing services. 

By using GORE and AGC Biologics, biopharmaceutical companies can improve downstream purification processes through increased productivity of the Protein A step, enabling a full single-use downstream process, which can eliminate column bioburden from storage, reduce manufacturing footprint, and help lower costs for clinical manufacturing and select scale commercial manufacturing.  

The collaboration includes the family of GORE® Protein Capture Devices with Protein A, which improves productivity in Protein A affinity purification, and provides high binding capacity at short residence times, alongside AGC Biologics’ mAb-based CDMO services. The joint offering from Gore and AGC Biologics is available across various sites in the AGC Biologics’ network.  

“This is a notable example of how our technology can support antibody-based therapies coming to market by addressing bottlenecks and boosting productivity” said William Barrett, Ph.D., Product Specialist, for GORE PharmBIO. “Our portfolio of GORE Protein A Capture Devices, with a unique expanded polytetrafluoroethylene (ePTFE) membrane, offers a scalable solution and we are thrilled to work with ACG Biologics so customers can reach their next clinical or commercial milestones.” 

AGC Biologics’ scientists have several decades of R&D experience in the monoclonal antibody space. The company has established more than 200 mammalian and microbial cell culture-based products. AGC Biologics’ historic work in implementing early-on high-throughput titer assessments of monoclonal cell lines helps streamline its early-phase mAb product programs.  

“Investments in new technologies like the GORE Protein Capture Device are important to meet our clients’ needs and address the changes in the monoclonal antibody market,” said Kasper Møller, Chief Technical Officer of AGC Biologics. “We are excited to offer this new technology for GMP manufacturing at relevant scales throughout our manufacturing network.” 

Learn more about GORE Protein Capture Devices with Protein A and get the latest information on upcoming events at www.gore.com/capturemoremAbs. 

To learn more about AGC Biologics’ cell line development services, visit https://www.agcbio.com/capabilities/process-development/cell-line-development.  

Learn more about AGC Biologics’ full line of mammalian-based manufacturing services at https://www.agcbio.com/capabilities/mammalian.  

http://mrem.bernama.com/viewsm.php?idm=44999